Physician profile
Swetha Mudunuri
NPI 1700149150
$1,481.71
in general payments reported to CMS, 2019-2025
18 companies · $213 in 2025
The $213 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $233 · 2021: $38.04 · 2022: $55.52 · 2023: $384 · 2024: $262 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $858.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $352.65 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $319.87 | 2020-2025 | Shingrix, Arexvy, Bexsero |
| Pfizer INC. | $183.85 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.05 | 2019-2024 | Jardiance |
| Amgen INC. | $109.07 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $55.02 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $42.66 | 2020-2021 | |
| Abbott Laboratories | $42.29 | 2022-2023 | Proclaim |
| Corcept Therapeutics | $39.45 | 2025 | Korlym |
| Cranial Technologies, INC | $31.65 | 2024-2025 | Doc Band |
| Philips North America LLC | $23.27 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $20.97 | 2023 | Uptravi, Opsumit |
| Sanofi Pasteur INC. | $20.76 | 2019 | |
| Qiagen, LLC | $20.37 | 2019 | |
| Mylan Specialty L.P. | $18.51 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hartmann USA, INC. | $17.64 | 2023 | Zetuvit Plus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.91 | 2019 | |
| Lilly USA, LLC | $14.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Swetha Mudunuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.